Replay available

Cabaletta Bio, Inc. (CABA) Q3 2024 Earnings Call

Cabaletta Bio, Inc. (NASDAQ: CABA) Q3 2024 earnings conference call, held 2024-11-20. Replay captured from the company's public earnings webcast.

Wed, November 20, 2024 at 8:00 AMendedReplay
Cabaletta Bio, Inc. (CABA) Q3 2024 Earnings Call

Hosted by

Featured presenters

Will Gramick

Representative, PrecisionAQ

Dr. Nick Wilkerson

Position Not Specified

Carl June

Director of the Center for Cellular Immunotherapies at Penn Medicine

David Chang

Chief Medical Officer

Gwen Bender

President of Science and Technology

Yifan Xu

Representative, Jeffries on behalf of Kelly Shih

Samantha Semenko

Representative, Citi

Douglas Sal

Representative, HC Wainwright

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cabaletta Bio, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:04.410 Good morning. At this time, I would like to welcome everyone to Caballero Bio's conference 00:00:04.410 -- 00:00:09.032 call and webcast. Currently, all participants are in a listen-only mode. 00:00:09.032 -- 00:00:12.512 After the speaker's remarks, there will be a question and answer session. 00:00:12.512 -- 00:00:17.674 Please note that this call is being recorded and is the property of Caballero Bio. 00:00:17.674 -- 00:00:22.795 Unauthorized recording, reproduction, or transmission of this call without the express 00:00:22.795 -- 00:00:26.316 written consent of Caballero Bio is strictly prohibited. 00:00:26.316 -- 00:00:28.982 I would now like to turn the call over to Will Gramick, 00:00:28.982 -- 00:00:32.823 of precision aq please go ahead 00:00:33.345 -- 00:00:38.389 thank you michelle good morning everyone and thank you for joining cabaletta bios conference 00:00:38.389 -- 00:00:43.413 call and webcast to discuss clinical and translational data from the first eight 00:00:43.413 -- 00:00:48.457 patients in the phase one two reset program in myositis lupus and 00:00:48.457 -- 00:00:53.589 systemic sclerosis that were presented at acr convergence 2024 00:00:53.661 -- 00:00:57.384 in oral and poster presentations over the weekend 00:00:57.384 -- 00:01:01.846 Before we begin, I encourage everyone to go to the Investors section of our website at 00:01:01.846 -- 00:01:03.467 cabalettabaya.com, 00:01:03.467 -- 00:01:08.389 where you can find the press release and slides related to today's call. 00:01:08.389 -- 00:01:12.411 I would like to remind everyone that we will be making forward-looking statements, which 00:01:12.411 -- 00:01:15.772 are based on our current expectations and beliefs. 00:01:15.772 -- 00:01:20.214 These statemen...